NCT00840801 - Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children | Biotech Hunter

Enrollment

302

Participants

Timeline

Start Date

February 6, 2009

Primary Completion Date

May 20, 2010

Study Completion Date

May 20, 2010

Conditions

Encephalitis, Tick-Borne

Interventions

BIOLOGICAL

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Subjects receive three vaccinations with FSME-IMMUN 0.25ml Junior on days 0, 28 and 360

BIOLOGICAL

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Subjects receive two vaccinations with Encepur 0.25ml Children on days 0 and 28 and a third vaccination with FSME-IMMUN 0.25ml Junior on day 360.

Trial Locations (8)

Unterer Graben 2, Eferding

Grieskirchnerstr.17, Wels

University Hospital Hradec Kralove, Vaccinal center, Clinic of infectious diseases, Sokolská 581, Hradec Králové

Private surgery of General Practitioner for children and juveniles, Havlíčkův Brod

Private surgery of General Practitioner for children and juveniles, Pardubice

Private surgery of General Practitioner for children and juveniles, Pardubice

Private surgery of General Practitioner for children and juveniles, Pardubice

Chemiku 129, Pardubice-Polabiny